Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jagat Pharma is a prominent Indian pharmaceutical company specializing in Ayurvedic healthcare, with a primary focus on non-surgical eye care solutions. The company is widely recognized for its flagship product, Isotine Eye Drops, which was developed by founder Dr. M.S. Basu to treat conditions such as immature cataracts, glaucoma, and macular degeneration. Beyond ophthalmology, Jagat Pharma produces a range of herbal supplements targeting bone health, immunity, and general wellness. The company emphasizes the integration of traditional Ayurvedic wisdom with modern quality control standards in its manufacturing processes. Headquartered in Bareilly, India, Jagat Pharma distributes its products to a global customer base through both retail and online channels. Their research efforts focus on validating ancient herbal remedies for modern clinical applications, particularly in chronic degenerative diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jagat Pharma.